VCR ventracor limited

abn research today

  1. 140 Posts.
    They xpect positive sentiment towards the sector and further clinical success to maintain the share price at current levels. They have increased their price target to A$3.17 per share.
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.